Category Archives: Drug Recalls & Safety Notices

FDA: Tainted products marketed as dietary supplements potentially dangerous

In a letter sent today to dietary supplement manufacturers, the U.S. Food and Drug Administration expressed concern about undeclared or deceptively labeled ingredients in products marketed as dietary supplements. These substances include the active ingredients in FDA-approved drugs or their analogs (closely-related drugs), or other compounds, such as novel synthetic steroids, that do not qualify as dietary ingredients.

U.S. Marshals seize FDA-regulated food stored at rodent-infested warehouse in New Mexico

U.S. Marshals, acting under a court order sought by the U.S. Food and Drug Administration, today seized chili pods, ground chili, crushed chili, and other chili products located in the rodent-infested food warehouse owned by Duran and Sons LLC in Derry, New Mexico. The New Mexico Environment Department had previously placed an embargo on all products in the company’s food warehouse on Nov. 17, 2010.

FDA Permits Wright County Egg to begin shipping shell eggs to consumers

November 30 2010 — FDA today notified Wright County Egg LLC of Galt, Iowa, that the company has FDA’s concurrence to begin shipping shell eggs directly to the consumer market from two hen houses on one of its six farms. The firm has not shipped eggs to the consumer market since August 2010, when the company’s eggs were associated with the multi-state outbreak of Salmonella Enteritidis (SE). (DSK)

FDA warns consumers not to use Vigor-25

Marketed as a ’male sexual stimulant,’ product contains hidden drug ingredient

The U.S. Food and Drug Administration says Vigor-25, a product marketed as a natural dietary supplement to enhance male sexual performance, should not be purchased or used because it contains sildenafil, the active ingredient in the prescription drug Viagra.

Xanodyne agrees to withdraw propoxyphene from the U.S. market

Xanodyne Pharmaceuticals Inc. which makes Darvon and Darvocet, the brand version of the painkiller propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food Administration. The FDA has also informed generic manufacturers of Xanodyne’s decision and they will be removing their propoxyphene-containing products from the market as well.